Enzon Pharma up 17% on high volume

• Nano cap Enzon Pharmaceuticals (OTC:ENZN +17.4%) heads north on more than a 4x surge in volume. No particular news accounts for the action. Star investor Carl Icahn owns a stake, always a point of interest for coat-tailers.
• The company generates all of its revenues from royalties on seven marketed products that incorporate its Customized PEGylation Linker Technology: PegIntron, Sylatron, Macugen, CIMZIA, OMONTYS, Oncaspar and Adagen.